CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Sabag Mark See "Remarks" | Sale | −44,710 | $44.14 | $2.0M | 80,760 |
| 2026-11-11 | Daniell Richard EVP, Europe Commercial | Sale | −20,003 | $42.80 | $856K | 55,755 |
| 2026-11-10 | Francis Richard D President and CEO | Sale 10b5-1 | −250,000 | $42.24 | $10.6M | 927,529 |
| 2026-11-09 | Daniell Richard EVP, Europe Commercial | Sale | −25,000 | $42.91 | $1.1M | 55,755 |
| 2026-11-09 | Weiss Amir Chief Accounting Officer | Sale | −662 | $43.15 | $29K | 20,164 |
| 2026-11-09 | Weiss Amir Chief Accounting Officer | Sale | −7,093 | $43.03 | $305K | 13,071 |
| 2026-11-09 | Weiss Amir Chief Accounting Officer | Sale | −9,534 | $43.03 | $410K | 3,537 |
| 2026-11-05 | Sabag Mark See "Remarks" | Sale | −46,000 | $41.93 | $1.9M | 80,760 |
| 2026-11-04 | Bergwerk Dov Interim Cheif Legal Officer | Sale | −17,505 | $41.72 | $730K | 11,943 |
| 2026-11-04 | Bergwerk Dov Interim Cheif Legal Officer | Sale | −8,755 | $41.72 | $365K | 11,943 |
| 2026-09-18 | Savage Brian Interim Chief Legal Officer | Sale | −4,503 | $38.69 | $174K | 11,339 |
| 2026-09-18 | Savage Brian Interim Chief Legal Officer | Sale | −2,525 | $39.15 | $99K | 8,814 |
| 2026-09-18 | Savage Brian Interim Chief Legal Officer | Sale | −314 | $38.70 | $12K | 8,500 |
| 2026-09-18 | MIGNONE ROBERTO Director | Sale | −367,600 | $39.06 | $14.4M | 0 |
| 2026-08-21 | Weiss Amir Chief Accounting Officer | Sale | −6,945 | $37.61 | $261K | 13,071 |
| 2026-08-21 | Weiss Amir Chief Accounting Officer | Sale | −2,500 | $37.63 | $94K | 13,071 |
| 2026-08-21 | Satchi-Fainaro Ronit Director | Sale | −415 | $37.25 | $15K | 111,986 |
| 2026-08-17 | Lippman Evan EVP, Business Development | Sale 10b5-1 | −18,600 | $36.57 | $680K | 25,591 |
| 2026-08-05 | Zaks Tal Zvi Director | Sale | −17 | $34.87 | $593 | 73,247 |
| 2026-08-03 | Jover Placid See "Remarks" | Sale 10b5-1 | −12,827 | $34.88 | $447K | 6,774 |
Page 1 of 16 · 317 trades